ATE271866T1 - Kombination von liponsäure und konjuensäuren zur behandlung diabetischer störungen - Google Patents
Kombination von liponsäure und konjuensäuren zur behandlung diabetischer störungenInfo
- Publication number
- ATE271866T1 ATE271866T1 AT01963002T AT01963002T ATE271866T1 AT E271866 T1 ATE271866 T1 AT E271866T1 AT 01963002 T AT01963002 T AT 01963002T AT 01963002 T AT01963002 T AT 01963002T AT E271866 T1 ATE271866 T1 AT E271866T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- combination
- lipoic acid
- conjuic
- acids
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 235000019136 lipoic acid Nutrition 0.000 title abstract 2
- 229960002663 thioctic acid Drugs 0.000 title abstract 2
- AGBQKNBQESQNJD-ZETCQYMHSA-N (S)-lipoic acid Chemical compound OC(=O)CCCC[C@H]1CCSS1 AGBQKNBQESQNJD-ZETCQYMHSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940126534 drug product Drugs 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000009469 supplementation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10045059A DE10045059A1 (de) | 2000-09-12 | 2000-09-12 | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
| PCT/EP2001/010501 WO2002022111A2 (de) | 2000-09-12 | 2001-09-11 | Kombination von liponsäure und konjuensäuren zur behandlung diabetischer störungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE271866T1 true ATE271866T1 (de) | 2004-08-15 |
Family
ID=7655916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01963002T ATE271866T1 (de) | 2000-09-12 | 2001-09-11 | Kombination von liponsäure und konjuensäuren zur behandlung diabetischer störungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030187058A1 (OSRAM) |
| EP (1) | EP1317264B1 (OSRAM) |
| JP (1) | JP2004508399A (OSRAM) |
| CN (1) | CN1216602C (OSRAM) |
| AT (1) | ATE271866T1 (OSRAM) |
| AU (1) | AU2001284057A1 (OSRAM) |
| DE (2) | DE10045059A1 (OSRAM) |
| DK (1) | DK1317264T3 (OSRAM) |
| ES (1) | ES2225593T3 (OSRAM) |
| WO (1) | WO2002022111A2 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697109B2 (en) * | 2000-08-16 | 2014-04-15 | Encore Health, Llc | Caged mercaptan and seleno-mercaptan compounds and methods of using them |
| US7914815B2 (en) * | 2000-08-16 | 2011-03-29 | Encore Health, Llc | Method for delivery of pharmaceuticals for treating or preventing presbyopia |
| US8647612B2 (en) * | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
| US7935332B2 (en) | 2000-08-16 | 2011-05-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
| US20050112113A1 (en) * | 2000-08-16 | 2005-05-26 | Till Jonathan S. | Presbyopia treatment by lens alteration |
| DE602004014716D1 (de) * | 2004-03-06 | 2008-08-14 | Cognis Ip Man Gmbh | Use of unsaturated fatty acids for the reduction of appetite or food intake |
| GB0426264D0 (en) * | 2004-11-30 | 2004-12-29 | Trigen Ltd | Compounds |
| JP4556061B2 (ja) * | 2006-07-27 | 2010-10-06 | ビーエイチエヌ株式会社 | ヒアルロン酸産生増強剤 |
| WO2008067403A2 (en) * | 2006-11-28 | 2008-06-05 | Encore Health Llc | Presbyopia treatment by lens alteration |
| CN101396357B (zh) * | 2007-09-29 | 2010-12-29 | 中国科学院上海生命科学研究院 | 硫辛酰胺在防治胰岛素抵抗中的用途 |
| US9044439B2 (en) | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
| WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
| ES2579173T3 (es) | 2009-06-15 | 2016-08-05 | Encore Health, Llc | Ésteres de colina para tratar presbicia y cataratas |
| EP3069612A3 (en) | 2009-06-15 | 2016-10-19 | Encore Health, LLC | Dithiol compounds, derivatives, and uses therefor |
| CN101671331B (zh) * | 2009-09-29 | 2011-06-01 | 寿光富康制药有限公司 | 硫辛酰维格列汀及其制备方法与应用 |
| JP5245061B2 (ja) * | 2010-05-12 | 2013-07-24 | ビーエイチエヌ株式会社 | 経口用老化防止剤及び美容方法 |
| US11160825B2 (en) | 2013-09-19 | 2021-11-02 | Research Foundation Of The State University Of New York | Methods and materials for treating diabetes or liver steatosis |
| WO2015050809A1 (en) * | 2013-10-01 | 2015-04-09 | Novozymes A/S | Processes of producing fermentation products |
| BR112016020181A8 (pt) | 2014-03-03 | 2021-06-29 | Encore Vision Inc | composições de ácido lipoico éster colina e métodos de uso. |
| CA2981138A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4343593C2 (de) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
| US5962030A (en) * | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
| WO1999029317A1 (en) * | 1997-12-12 | 1999-06-17 | Purdue Research Foundation | Methods and compositions for treating diabetes |
| US6440931B1 (en) * | 1999-02-23 | 2002-08-27 | Natural Corporation | Conjugated linoleic acid in treatment and prophylaxis of diabetes |
| US6288106B1 (en) * | 1999-05-25 | 2001-09-11 | Chronorx, Llc | Processes for the synthesis and use of various α-lipoic acid complexes |
| WO2001056572A1 (en) * | 2000-02-02 | 2001-08-09 | Metagenics, Inc. | Compositions and methods for promoting healthy joints |
-
2000
- 2000-09-12 DE DE10045059A patent/DE10045059A1/de not_active Withdrawn
-
2001
- 2001-09-11 US US10/363,658 patent/US20030187058A1/en not_active Abandoned
- 2001-09-11 DE DE50103029T patent/DE50103029D1/de not_active Expired - Lifetime
- 2001-09-11 DK DK01963002T patent/DK1317264T3/da active
- 2001-09-11 WO PCT/EP2001/010501 patent/WO2002022111A2/de not_active Ceased
- 2001-09-11 AT AT01963002T patent/ATE271866T1/de active
- 2001-09-11 JP JP2002526363A patent/JP2004508399A/ja active Pending
- 2001-09-11 EP EP01963002A patent/EP1317264B1/de not_active Expired - Lifetime
- 2001-09-11 AU AU2001284057A patent/AU2001284057A1/en not_active Abandoned
- 2001-09-11 ES ES01963002T patent/ES2225593T3/es not_active Expired - Lifetime
- 2001-09-11 CN CN018155413A patent/CN1216602C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1317264B1 (de) | 2004-07-28 |
| JP2004508399A (ja) | 2004-03-18 |
| EP1317264A2 (de) | 2003-06-11 |
| ES2225593T3 (es) | 2005-03-16 |
| CN1216602C (zh) | 2005-08-31 |
| CN1455670A (zh) | 2003-11-12 |
| WO2002022111A3 (de) | 2003-02-27 |
| DK1317264T3 (da) | 2004-11-29 |
| AU2001284057A1 (en) | 2002-03-26 |
| US20030187058A1 (en) | 2003-10-02 |
| WO2002022111A2 (de) | 2002-03-21 |
| DE50103029D1 (de) | 2004-09-02 |
| DE10045059A1 (de) | 2002-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE271866T1 (de) | Kombination von liponsäure und konjuensäuren zur behandlung diabetischer störungen | |
| RU2395500C2 (ru) | 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
| BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
| PH12022551482A1 (en) | 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | |
| BR0306846A (pt) | Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido | |
| EA200500377A1 (ru) | Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf) | |
| TR200100894T2 (tr) | Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları. | |
| DE50011582D1 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| ATE389400T1 (de) | Cis-2,4,5- triphenyl-imidazoline und ihre verwendung bei der behandlung von tumoren | |
| EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
| BG106343A (bg) | Амиди на карбоксилни киселини, лекарствени средства които ги съдържат, тяхното приложение и получаване | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| ATE428711T1 (de) | Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3- cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon | |
| DE60232173D1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
| IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| ATE267816T1 (de) | Tan-1057 derivate | |
| BG106847A (bg) | Заместени пиперазинови производни като инхибиторина микрозомалния триглицеридпренасящ протеин (mtp) | |
| CY1112057T1 (el) | Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι | |
| ATE151288T1 (de) | N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt | |
| ATE415965T1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
| EA200400707A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| DE69418110D1 (de) | N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten | |
| ATE386741T1 (de) | Pyrazolamide zur behandlung von hiv-infektionen | |
| NO993911D0 (no) | Remedier/Forebygningsmidler for åndedrettssykdommer |